• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION SMART CONTROL NITINOL STENT SYSTEM; SELF EXPANDING STENTS (NIO)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION SMART CONTROL NITINOL STENT SYSTEM; SELF EXPANDING STENTS (NIO) Back to Search Results
Catalog Number C08060ML
Device Problem Occlusion Within Device (1423)
Patient Problem Reocclusion (1985)
Event Date 12/03/2014
Event Type  Injury  
Event Description
As reported by the (b)(4) smart pms for sfa study, one year after pta with stenting involving three smart control stents, the patient had claudication.Ppi was performed 6 months was performed due to total occlusion in the stents.The patient received 2 days later.The target lesion was the middle distal of left superficial femoral artery.The rate of stenosis was 100%.
 
Manufacturer Narrative
(b)(4).The product remains implanted and is thus not available for analysis.Additional information is pending and will be submitted within 30 days upon receipt.This is one of 3 products involved with the reported event and are associated manufacturer report numbers 9616099-2014-00833, 9616099-2014-00834 and 9616099-2014-00835.
 
Manufacturer Narrative
Additional information was received that the patient¿s admitting diagnosis prior to the stent placement is unknown.The medications are unknown.Medical history included intermittent claudication and in-stent restenosis.The diameter of the target vessel and the target lesion length are unknown.The lesion was mildly calcified with no vessel tortuosity.It is not known if the lesion was pre-dilated during the initial procedure.It is also unknown if the stents were overlapping.The original lesion is unknown, but after the patient returned, there was 100% stenosis.Additional information is pending and will be submitted within 30 days upon receipt.This is one of 3 products involved with the reported event and are associated manufacturer report numbers 9616099-2014-00833, 9616099-2014-00834 and 9616099-2014-00835.
 
Manufacturer Narrative
Initial reporter's name is (b)(6).Contact information is unknown.As reported by the (b)(4), one year after pta with stenting involving three smart control stents, a 61 year-old male patient with medical history including intermittent claudication and in-stent restenosis had claudication.Ppi was performed 6 months due to total occlusion in the stents.The patient received 2 days later.The target lesion was the middle distal of left superficial femoral artery.The rate of stenosis was 100%.The patient¿s admitting diagnosis prior to the stent placement is unknown.The medications are unknown.The diameter of the target vessel and the target lesion length are unknown.The lesion was mildly calcified with no vessel tortuosity.It is not known if the lesion was pre-dilated during the initial procedure.It is also unknown if the stents were overlapping.The stenosis of the original lesion is unknown, but after the patient returned, there was 100% stenosis.A review of the manufacturing documentation associated with this lot presented no issues during the manufacturing process that can be related to the reported complaint.In-stent restenosis (isr) is associated with the progression of atherosclerotic disease and is a known potential adverse event following stent implantation and does not represent a device failure.Intra-arterial stent placement is a treatment of the disease process, it is not a preventive or cure for the progression of symptoms of atherosclerotic artery disease.There is no information to suggest that there is a design or manufacturing related issue, therefore, no corrective action will be taken.This is one of 3 products involved with the reported event and are associated manufacturer report numbers 9616099-2014-00833, 9616099-2014-00834 and 9616099-2014-00835.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMART CONTROL NITINOL STENT SYSTEM
Type of Device
SELF EXPANDING STENTS (NIO)
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60th avenue
miami lakes FL
Manufacturer Contact
cecil navajas
circuito interior norte #1820
juarez chihuahua 32580
MX   32580
7863133880
MDR Report Key4364932
MDR Text Key5237224
Report Number9616099-2014-00833
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P020036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 01/29/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/29/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2015
Device Catalogue NumberC08060ML
Device Lot Number15817156
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/29/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/14/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Weight72
-
-